Table 1 Selected summary of evidence-based guideline recommendations
Organization | Year | Country | Recommendation |
|---|---|---|---|
Canadian Task Force on Preventive Health Care | 2014 | Canada | <55 or ≥70: Recommended against screening (strong recommendation, low-quality evidence) 55 to 69: Recommended against screening (weak recommendation; moderate quality evidence) |
American College of Physicians | 2015 | USA | <50 or ≥70: Recommended against screening 50 to 69: Recommended shared decision making |
Members of the rapid recommendation panel | 2018 | International | Recommended against systematic PSA-based screening (weak recommendation). Shared decision making is needed for men considering screening. |
U.S. Preventive Services Task Force | 2018 | USA | 55 to 69: Recommended shared decision making ≥70: Recommended against screening |
American Academy of Family Physicians | 2019 | USA | Recommended against screening. For individuals aged 55 to 69 and considering periodic screening: Recommended shared decision making |
UK National Screening Committee | 2020 | UK | Recommended against systematic population screening |